E-Learning

US stock markets to remain closed in honor of Jimmy Carter on National Day of Mourning

U.S. stock markets will remain closed on Jan. 9 in honor of former President Jimmy Carter, continuing a long-held Wall Street tradition in mourning the nation’s leaders. Both the New York Stock Exchange and Nasdaq announced this week that they plan to close their equity and options markets next Thursday in observance of a National Day of Mourning for the 39th U.S. president and global humanitarian. Carter died on Sunday at his home in Plains, Georgia.

Read more

Boeing on track to be 2024's biggest loser in Dow Jones Index

Boeing's shares opened the year at $257.50. Regardless, Boeing has struggled to produce close to its maximum-allowed 737 planes per month due to supply-chain problems, quality issues and a seven-week-long strike that temporarily shut down most of its commercial aircraft production, including the 737 program. Boeing also continued to post massive losses from its commercial, military and space programs throughout the year.

Read more

Posh New York City Suburb to Tap Bond Market for $189 Million

(Bloomberg) -- Westchester County plans to issue roughly $189 million in general obligation bonds, with Fitch Ratings giving the debt a top-tier AAA rating. Most Read from BloombergDetroit’s Michigan Central Is the Building Revival Story of 2024Burned Out Parents Need Better Public SpacesMigrant Crisis Pushed US Homelessness to Record High in 2024The affluent enclave, home to New York City suburbs like Scarsdale and Rye, will use the proceeds from the sale expected in February for various capita

Read more

Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?

Kazia Therapeutics Limited (NASDAQ:KZIA) stock is trading lower on Tuesday after the company provided a regulatory update on paxalisib for glioblastoma (GBM) following its Type C clinical meeting with the FDA. In July 2024, the company reported topline results from the GBM-AGILE study in which newly diagnosed unmethylated patients with glioblastoma treated with paxalisib showed a clinically meaningful improvement in a prespecified secondary analysis for overall survival (OS) compared to standard

Read more